Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-24-000724
Filing Date
2024-01-03
Accepted
2024-01-03 13:49:05
Documents
2

Document Format Files

Seq Description Document Type Size
1 DEFA14A tm241794d1_defa14a.htm DEFA14A 10873
2 GRAPHIC tm241794d1_defa14aimg001.jpg GRAPHIC 5316
  Complete submission text file 0001104659-24-000724.txt   19492
Mailing Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059
Business Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059 908-574-4770
Bellerophon Therapeutics, Inc. (Filer) CIK: 0001600132 (see all company filings)

EIN.: 473116175 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36845 | Film No.: 24505446
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)